Large-scale testing (Phase 3)Study completedNCT01870895
What this trial is testing
Assess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS)
Who this might be right for
Diarrhea-predominant Irritable Bowel Syndrome
Astellas Pharma Inc 577